PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
about
The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinomaProtein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung AdenocarcinomaEndothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients.PKCζ Promotes Breast Cancer Invasion by Regulating Expression of E-cadherin and Zonula Occludens-1 (ZO-1) via NFκB-p65.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesisTargeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC.In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.Ovarian cancer stem cells: still an elusive entity?Rewiring cell polarity signaling in cancer.Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells.A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.Protein kinase C in cancer: The top five unanswered questions.A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome."Atypical" regulation of Hedgehog-dependent cancers.Small interfering RNA-induced inhibition of epithelial cell transforming sequence 2 suppresses the proliferation, migration and invasion of osteosarcoma cells.PRKCI promotes immune suppression in ovarian cancer.Developing a genetic signature to predict drug response in ovarian cancer.
P2860
Q24337113-0583DE78-B888-41AC-B95F-9E6584A6D2AAQ28115044-286C5228-7AE8-40E8-9EC6-C99BB637DC52Q34624192-2F4AE6AC-B97C-4674-ABFE-AD3F05E61B62Q35954798-2C02C711-D6B4-4E02-A7FD-A44B53AC09F5Q36288745-271AD20E-1F24-4ADD-BEB9-B5377E076F26Q36510237-57AD97FB-4D3C-4DDE-8321-2B3C93112EDDQ37520978-E5FC328E-0C22-4A94-B94E-5941535AFBB4Q37673912-50A81A40-7FBF-438D-A397-37403C581123Q37706134-2AA5B752-BBD0-48F0-BB25-6F8753BAA7F9Q37713683-E4FAF3D7-D11A-48E2-8C3E-2DF8E157779CQ38196268-6EC213B0-7F64-4C34-9B4B-1305DA54154AQ38742633-315B2B30-20B3-4907-B702-7DD8E3EC3578Q38882024-ACDAC9DD-C840-4932-A7FA-C4FC591C72DDQ39098659-22FE5AE1-3715-4401-A32E-D47BB3D8AB45Q39192174-F069E207-9A5F-46E7-9696-8749807925B7Q39708962-B481AC78-9FA9-46D2-A46D-C288558C5C61Q41982295-4D61259A-3498-4AD7-B84A-F1CC53129BE1Q47154650-7DA423B2-4ACF-429F-AC96-C1CA59779587Q55028564-9803A47A-3232-438E-90DF-F0A9C83BFEF4
P2860
PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@en
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@nl
type
label
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@en
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@nl
prefLabel
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@en
PKCι maintains a tumor-initiat ...... red for ovarian tumorigenesis.
@nl
P2860
P1476
PKCι maintains a tumor-initiat ...... ired for ovarian tumorigenesis
@en
P2093
Alan P Fields
P2860
P304
P356
10.1158/1541-7786.MCR-13-0371-T
P577
2013-10-30T00:00:00Z